The Hydration Pharmaceuticals Company (ASX:HPC)
ASX announcement history & article coverage
Transparent by design.
Announcments by The Hydration Pharmaceuticals Company (ASX:HPC) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Proposed issue of securities - HPC
Letter to UMP Shareholders and Retention Form
Prospectus - Non Renounceable Rights Issue
Hydration Pharmaceuticals launches A$1.435 million entitlement offer with free options
Rights Issue and UMP Share Sale Facility
HPC launches A$1.43 million entitlement offer with free-attaching options
Results of Extraordinary General Meeting
July and August 2026 Trading Update
Hydralyte cuts two-month EBITDA loss 75% as US business reaches maiden monthly profit
Letter to Shareholders regarding EGM
Notice of Extraordinary General Meeting/Proxy Form
Appendix 4D and FY26 Half Year Financial Report
Q2 FY26 Quarterly Activities Report (App 4C)
Hydralyte USA reports 13.6% sales growth, cost savings, and strategic placement in Q2 CY26